Doctor profile · Federal record
Dr. Kevin Pinski, M.D.
Dermatology Physician (CMS: Dermatology) · Procedural Dermatology Physician · Chicago, IL
- NPI 1003973413
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 35 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
150 N Michigan Ave Ste 1200
Chicago, IL 606017605
(312) 263-4625
fax (312) 263-5029 - Additional location
-
374 Larry Power RD
Bourbonnais, IL 609145187
(815) 933-2227
fax (815) 933-5278
Credentials & registration
- NPI registered
- January 2007 — 19 yrs on file
- Profile last updated
- September 20, 2022
- Year of graduation
- 1991 — 35 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Illinois #036078458
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1003973413. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
2,801
Distinct HCPCS
10
Medicare allowed
$134,787
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 1,137 | 147 | $7 | |
17000 |
Destruction of precancer skin growth, 1 growth | 355 | 188 | $58 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 331 | 217 | $93 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 170 | 134 | $58 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 158 | 100 | $132 | |
88305 |
Pathology examination of tissue using a microscope, intermediate complexity | 140 | 97 | $39 | |
11102 |
Biopsy of related skin growth, first growth | 107 | 80 | $96 | |
17110 |
Destruction of skin growth, 1-14 growths | 89 | 67 | $116 | |
11103 |
Biopsy of related skin growth, each additional growth | 85 | 39 | $52 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 49 | 29 | $1 |
In context: peer comparison
Among 58 peers in this city , average services per provider: 117. This provider delivers 24× the peer median.Open Payments
Industry payments received
All-time total
$809
Transactions
38
Manufacturers
12
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 18 | $294.63 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $106.45 | |
| PFIZER INC. | 4 | $97.06 | |
| GENZYME CORPORATION | 2 | $60.96 | |
| Regeneron Healthcare Solutions, Inc. | 2 | $46.50 | |
| Janssen Biotech, Inc. | 2 | $45.15 | |
| LEO Pharma Inc. | 2 | $37.26 | |
| Galderma Laboratories, L.P. | 2 | $35.98 | |
| Amgen Inc. | 1 | $28.32 | |
| Dermavant Sciences, Inc. | 1 | $22.20 | |
| Novartis Pharmaceuticals Corporation | 1 | $18.11 | |
| Krystal Biotech Inc | 1 | $16.28 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
287
Patients
97
Total drug cost
$163,235
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Finasteride | Generic | 70 | 24 | $1,338 |
| Minocycline Hcl | Generic | 34 | 11 | $902 |
| Clobetasol Propionate | Generic | 28 | 18 | $2,415 |
| Terbinafine Hcl | Generic | 28 | 19 | $333 |
| Valacyclovir (Valacyclovir Hcl) | Brand | 25 | 13 | $823 |
| Dupixent Syringe (Dupilumab) | Brand | 22 | 0 | $87,423 |
| Desoximetasone | Generic | 14 | 12 | $1,301 |
| Fluocinolone Acetonide | Generic | 14 | 0 | $1,108 |
| Triamcinolone Acetonide | Generic | 14 | 0 | $402 |
| Dupixent Pen (Dupilumab) | Brand | 13 | 0 | $66,470 |
Frequently asked questions
What is Dr. Kevin Pinski's medical specialty?
Dr. Kevin Pinski practices Dermatology Physician in Chicago, IL.
Where does Dr. Kevin Pinski practice?
Dr. Kevin Pinski practices at 150 N Michigan Ave Ste 1200, Chicago, IL 606017605. Office phone: 3122634625.
What is Dr. Kevin Pinski's NPI?
Dr. Kevin Pinski's National Provider Identifier (NPI) is 1003973413, issued by NPPES.
Does Dr. Kevin Pinski accept Medicare assignment?
Yes. Dr. Kevin Pinski accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Kevin Pinski commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Destruction of precancer skin growth, 1 growth (HCPCS 17000); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.